News
Guillain-Barre syndrome is a rare but serious condition which needs urgent treatment in hospital to prevent it progressing.
The UK's medicines regulator has warned NHS healthcare staff about an increased risk of a condition affecting the nerves in ...
OVER 20 people developed a potentially paralysing illness after getting the respiratory syncytial virus (RSV) vaccine. The UK ...
Hospital readmission risk in pediatric patients was higher in those who were first admitted for RSV than in those who were first admitted for influenza or hMPV.
Vaccination programs have saved lives – and saved the Canadian economy and health care system significant resources as well ...
Merck & Co., Inc. (NYSE:MRK) is one of the 10 Best Value Stocks to Buy According to Billionaires. The company announced that ...
Health Secretary Robert F. Kennedy Jr. endorsed the expanded use of RSV vaccines for people 50 through 59 years old who are ...
The Trump administration’s new vaccine advisers endorsed this fall's flu vaccines late last week, but only those that don't ...
Immunizations “are not all good or bad,” says the chair of the overhauled panel.
The eight new ACIP members met for the first time June 25 after Kennedy fired all 17 original members of the committee June 9 ...
Kennedy’s decision to replace ACIP wholesale and the comments he has made about deviating from standard vaccine policymaking ...
Enflonsia is an extended half-life RSV fusion glycoprotein neutralizing monoclonal antibody that is designed to provide durable protection through 5 months.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results